When shouldn't we retransplant?

被引:54
作者
Zimmerman, MA [1 ]
Ghobrial, RM [1 ]
机构
[1] Univ Calif Los Angeles, Dumont Transplant Ctr, David Geffen Sch Med,Pfleger Liver Inst, Dept Surg,Div Liver & Pancreas Transplantat, Los Angeles, CA 90095 USA
关键词
RECURRENT HEPATITIS-C; LIVER-TRANSPLANTATION; POOR SURVIVAL; MODEL; PROGRESSION; EXPERIENCE; FAILURE; DISEASE;
D O I
10.1002/lt.20599
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1. In the setting of early graft failure after primary transplantation, orthotopic liver retransplantation (re-OLT) should be undertaken within the first 7 days, but it should be discouraged within 8-30 days, since re-OLT within this intermediate frame is associated with the worst results. 2. Late retransplantation should be cautioned in severely ill patients who exhibit Model for End-Stage Liver Disease (MELD) scores > 25, require mechanical ventilation, have advanced renal insufficiency, and in advanced-age recipients. 3. Re-OLT should not be undertaken with extended and older donors particularly when retransplantation for recurrent disease is considered. 4. Prognostic models that take into account the severity of disease and the effect of the organ to be transplanted should be developed to better predict outcomes after re-OLT. 5. Accurate definitions of acceptable outcomes after retransplantation and "futile re-OLT" are desperately needed.
引用
收藏
页码:S14 / S20
页数:7
相关论文
共 24 条
[1]   Decision for retransplantation of the liver - An experience- and cost-based analysis [J].
Azoulay, D ;
Linhares, MM ;
Huguet, E ;
Delvart, V ;
Castaing, D ;
Adam, R ;
Ichai, P ;
Saliba, F ;
Lemoine, A ;
Samuel, D ;
Bismuth, H .
ANNALS OF SURGERY, 2002, 236 (06) :713-721
[2]   HCV-related fibrosis progression following liver transplantation:: increase in recent years [J].
Berenguer, M ;
Ferrell, L ;
Watson, J ;
Prieto, M ;
Kim, M ;
Rayón, M ;
Córdoba, J ;
Herola, A ;
Ascher, N ;
Mir, J ;
Berenguer, J ;
Wright, TL .
JOURNAL OF HEPATOLOGY, 2000, 32 (04) :673-684
[3]   Retransplantation for hepatic allograft failure: Prognostic modeling and ethical considerations [J].
Biggins, SW ;
Beldecos, A ;
Rabkin, JM ;
Rosen, HR .
LIVER TRANSPLANTATION, 2002, 8 (04) :313-322
[4]   Retransplantation for recurrent hepatitis C in the MELD era: Maximizing utility [J].
Burton, JR ;
Sonnenberg, A ;
Rosen, HR .
LIVER TRANSPLANTATION, 2004, 10 (10) :S59-S64
[5]   Analysis of long-term outcomes of 3200 liver transplantations over two decades - A single-center experience [J].
Busuttil, RW ;
Farmer, DG ;
Yersiz, H ;
Hiatt, JR ;
McDiarmid, SV ;
Goldstein, LI ;
Saab, S ;
Han, S ;
Durazo, F ;
Weaver, M ;
Cao, C ;
Chen, T ;
Lipshutz, GS ;
Holt, C ;
Gordon, S ;
Gornbein, J ;
Amersi, F ;
Ghobrial, RM .
ANNALS OF SURGERY, 2005, 241 (06) :905-916
[6]   Frequency of nonalcoholic steatohepatitis as a cause of advanced liver disease [J].
Charlton, M ;
Kasparova, P ;
Weston, S ;
Lindor, K ;
Maor-Kendler, Y ;
Wiesner, RH ;
Rosen, CB ;
Batts, KP .
LIVER TRANSPLANTATION, 2001, 7 (07) :608-614
[7]   Hepatic retransplantation - An analysis of risk factors associated with outcome [J].
Doyle, HR ;
Morelli, F ;
McMichael, J ;
Doria, C ;
Aldrighetti, L ;
Starzl, TE ;
Marino, IR .
TRANSPLANTATION, 1996, 61 (10) :1499-1505
[8]  
Facciuto M, 2000, LIVER TRANSPLANT, V6, P174, DOI 10.1016/S1527-6465(00)80007-6
[9]   Pretransplant model to predict posttransplant survival in liver transplant patients [J].
Ghobrial, RM ;
Gornbein, J ;
Steadman, R ;
Danino, N ;
Markmann, JF ;
Holt, C ;
Anselmo, D ;
Amersi, F ;
Chen, P ;
Farmer, DG ;
Han, S ;
Derazo, F ;
Saab, S ;
Goldstein, LI ;
McDiarmid, SV ;
Busuttil, RW .
ANNALS OF SURGERY, 2002, 236 (03) :315-323
[10]   Retransplantation for recurrent hepatitis C [J].
Ghobrial, RM .
LIVER TRANSPLANTATION, 2002, 8 (10) :S38-S43